MCW News

In the 5-year follow-up of the pivotal SOLO-1 trial in women with advanced ovarian cancer and a BRCA1/2 mutation, maintenance treatment with olaparib led to a doubling in progression-free survival. William H. Bradley, MD, presented these findings at the Society of Gynecologic Oncology (SGO) 2021...

Lisa Lockett-Neumuth, CNM, APNP joined the Department of Obstetrics and Gynecology in August, 2020. She received her Bachelors of Science in Nursing undergraduate degree from Marquette University in 2006....